nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.14	0.248	CbGbCtD
Solifenacin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.106	0.188	CbGbCtD
Solifenacin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0913	0.161	CbGbCtD
Solifenacin—CYP3A4—Prednisolone—ankylosing spondylitis	0.0901	0.159	CbGbCtD
Solifenacin—CYP3A4—Prednisone—ankylosing spondylitis	0.0851	0.15	CbGbCtD
Solifenacin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0531	0.0937	CbGbCtD
Solifenacin—Obstructive airways disorder—Methotrexate—ankylosing spondylitis	0.0155	0.0357	CcSEcCtD
Solifenacin—Glaucoma—Prednisolone—ankylosing spondylitis	0.00768	0.0177	CcSEcCtD
Solifenacin—Glaucoma—Triamcinolone—ankylosing spondylitis	0.00707	0.0163	CcSEcCtD
Solifenacin—Glaucoma—Methylprednisolone—ankylosing spondylitis	0.00705	0.0163	CcSEcCtD
Solifenacin—Glaucoma—Dexamethasone—ankylosing spondylitis	0.00641	0.0148	CcSEcCtD
Solifenacin—Glaucoma—Betamethasone—ankylosing spondylitis	0.00641	0.0148	CcSEcCtD
Solifenacin—Glaucoma—Prednisone—ankylosing spondylitis	0.00558	0.0129	CcSEcCtD
Solifenacin—Liver disorder—Methotrexate—ankylosing spondylitis	0.00516	0.0119	CcSEcCtD
Solifenacin—Delirium—Prednisone—ankylosing spondylitis	0.00489	0.0113	CcSEcCtD
Solifenacin—Dry eye—Dexamethasone—ankylosing spondylitis	0.00446	0.0103	CcSEcCtD
Solifenacin—Dry eye—Betamethasone—ankylosing spondylitis	0.00446	0.0103	CcSEcCtD
Solifenacin—Dry skin—Prednisolone—ankylosing spondylitis	0.00385	0.00888	CcSEcCtD
Solifenacin—Muscular weakness—Prednisolone—ankylosing spondylitis	0.0037	0.00854	CcSEcCtD
Solifenacin—Cystitis noninfective—Methotrexate—ankylosing spondylitis	0.00343	0.00792	CcSEcCtD
Solifenacin—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.00341	0.00786	CcSEcCtD
Solifenacin—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.0034	0.00784	CcSEcCtD
Solifenacin—Cystitis—Methotrexate—ankylosing spondylitis	0.00339	0.00783	CcSEcCtD
Solifenacin—Influenza—Triamcinolone—ankylosing spondylitis	0.00334	0.0077	CcSEcCtD
Solifenacin—Dry skin—Betamethasone—ankylosing spondylitis	0.00321	0.00741	CcSEcCtD
Solifenacin—Dry skin—Dexamethasone—ankylosing spondylitis	0.00321	0.00741	CcSEcCtD
Solifenacin—Bladder pain—Methotrexate—ankylosing spondylitis	0.00318	0.00733	CcSEcCtD
Solifenacin—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.00309	0.00713	CcSEcCtD
Solifenacin—Muscular weakness—Betamethasone—ankylosing spondylitis	0.00309	0.00713	CcSEcCtD
Solifenacin—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00297	0.00685	CcSEcCtD
Solifenacin—Infestation—Methylprednisolone—ankylosing spondylitis	0.00297	0.00685	CcSEcCtD
Solifenacin—Dry skin—Prednisone—ankylosing spondylitis	0.0028	0.00645	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.0027	0.00624	CcSEcCtD
Solifenacin—Muscular weakness—Prednisone—ankylosing spondylitis	0.00269	0.00621	CcSEcCtD
Solifenacin—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00265	0.00612	CcSEcCtD
Solifenacin—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00265	0.00612	CcSEcCtD
Solifenacin—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00262	0.00604	CcSEcCtD
Solifenacin—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00249	0.00575	CcSEcCtD
Solifenacin—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00247	0.00571	CcSEcCtD
Solifenacin—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00242	0.00558	CcSEcCtD
Solifenacin—Hallucination—Betamethasone—ankylosing spondylitis	0.00241	0.00556	CcSEcCtD
Solifenacin—Hallucination—Dexamethasone—ankylosing spondylitis	0.00241	0.00556	CcSEcCtD
Solifenacin—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00241	0.00555	CcSEcCtD
Solifenacin—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.0024	0.00554	CcSEcCtD
Solifenacin—Vision blurred—Prednisolone—ankylosing spondylitis	0.00238	0.0055	CcSEcCtD
Solifenacin—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00236	0.00543	CcSEcCtD
Solifenacin—Depression—Prednisone—ankylosing spondylitis	0.00235	0.00541	CcSEcCtD
Solifenacin—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00234	0.00539	CcSEcCtD
Solifenacin—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00232	0.00535	CcSEcCtD
Solifenacin—Angioedema—Prednisolone—ankylosing spondylitis	0.00231	0.00533	CcSEcCtD
Solifenacin—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00228	0.00525	CcSEcCtD
Solifenacin—Eye disorder—Betamethasone—ankylosing spondylitis	0.00227	0.00523	CcSEcCtD
Solifenacin—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00227	0.00523	CcSEcCtD
Solifenacin—Angiopathy—Dexamethasone—ankylosing spondylitis	0.0022	0.00507	CcSEcCtD
Solifenacin—Angiopathy—Betamethasone—ankylosing spondylitis	0.0022	0.00507	CcSEcCtD
Solifenacin—Hypertension—Prednisolone—ankylosing spondylitis	0.00218	0.00504	CcSEcCtD
Solifenacin—Angioedema—Triamcinolone—ankylosing spondylitis	0.00213	0.0049	CcSEcCtD
Solifenacin—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00212	0.00489	CcSEcCtD
Solifenacin—Hallucination—Prednisone—ankylosing spondylitis	0.0021	0.00485	CcSEcCtD
Solifenacin—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00208	0.00479	CcSEcCtD
Solifenacin—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00206	0.00476	CcSEcCtD
Solifenacin—Dysuria—Methotrexate—ankylosing spondylitis	0.00206	0.00475	CcSEcCtD
Solifenacin—Cough—Triamcinolone—ankylosing spondylitis	0.00203	0.00468	CcSEcCtD
Solifenacin—Tachycardia—Prednisolone—ankylosing spondylitis	0.00201	0.00465	CcSEcCtD
Solifenacin—Hypertension—Triamcinolone—ankylosing spondylitis	0.00201	0.00463	CcSEcCtD
Solifenacin—Hypertension—Methylprednisolone—ankylosing spondylitis	0.002	0.00462	CcSEcCtD
Solifenacin—Eye disorder—Prednisone—ankylosing spondylitis	0.00197	0.00455	CcSEcCtD
Solifenacin—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00197	0.00453	CcSEcCtD
Solifenacin—Infestation—Methotrexate—ankylosing spondylitis	0.00197	0.00453	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00196	0.00453	CcSEcCtD
Solifenacin—Depression—Methotrexate—ankylosing spondylitis	0.00196	0.00452	CcSEcCtD
Solifenacin—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00194	0.00447	CcSEcCtD
Solifenacin—Renal failure—Methotrexate—ankylosing spondylitis	0.00193	0.00446	CcSEcCtD
Solifenacin—Angioedema—Dexamethasone—ankylosing spondylitis	0.00193	0.00445	CcSEcCtD
Solifenacin—Angioedema—Betamethasone—ankylosing spondylitis	0.00193	0.00445	CcSEcCtD
Solifenacin—Angiopathy—Prednisone—ankylosing spondylitis	0.00192	0.00442	CcSEcCtD
Solifenacin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00191	0.00441	CcSEcCtD
Solifenacin—Immune system disorder—Prednisone—ankylosing spondylitis	0.00191	0.0044	CcSEcCtD
Solifenacin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.0019	0.00438	CcSEcCtD
Solifenacin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00189	0.00437	CcSEcCtD
Solifenacin—Infection—Triamcinolone—ankylosing spondylitis	0.00189	0.00435	CcSEcCtD
Solifenacin—Infection—Methylprednisolone—ankylosing spondylitis	0.00188	0.00434	CcSEcCtD
Solifenacin—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00186	0.00429	CcSEcCtD
Solifenacin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00186	0.00428	CcSEcCtD
Solifenacin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00185	0.00427	CcSEcCtD
Solifenacin—Mental disorder—Prednisone—ankylosing spondylitis	0.00185	0.00427	CcSEcCtD
Solifenacin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00185	0.00426	CcSEcCtD
Solifenacin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00184	0.00424	CcSEcCtD
Solifenacin—Malnutrition—Prednisone—ankylosing spondylitis	0.00184	0.00424	CcSEcCtD
Solifenacin—Hypertension—Betamethasone—ankylosing spondylitis	0.00182	0.0042	CcSEcCtD
Solifenacin—Hypertension—Dexamethasone—ankylosing spondylitis	0.00182	0.0042	CcSEcCtD
Solifenacin—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00175	0.00404	CcSEcCtD
Solifenacin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00174	0.00402	CcSEcCtD
Solifenacin—Vision blurred—Prednisone—ankylosing spondylitis	0.00173	0.004	CcSEcCtD
Solifenacin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00173	0.00399	CcSEcCtD
Solifenacin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00172	0.00397	CcSEcCtD
Solifenacin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00172	0.00397	CcSEcCtD
Solifenacin—Infection—Dexamethasone—ankylosing spondylitis	0.00171	0.00395	CcSEcCtD
Solifenacin—Infection—Betamethasone—ankylosing spondylitis	0.00171	0.00395	CcSEcCtD
Solifenacin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.0017	0.00392	CcSEcCtD
Solifenacin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00169	0.0039	CcSEcCtD
Solifenacin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00169	0.0039	CcSEcCtD
Solifenacin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00168	0.00388	CcSEcCtD
Solifenacin—Tachycardia—Betamethasone—ankylosing spondylitis	0.00168	0.00388	CcSEcCtD
Solifenacin—Angioedema—Prednisone—ankylosing spondylitis	0.00168	0.00387	CcSEcCtD
Solifenacin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00167	0.00385	CcSEcCtD
Solifenacin—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00167	0.00385	CcSEcCtD
Solifenacin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00167	0.00385	CcSEcCtD
Solifenacin—Eye disorder—Methotrexate—ankylosing spondylitis	0.00165	0.0038	CcSEcCtD
Solifenacin—Urticaria—Prednisolone—ankylosing spondylitis	0.00164	0.00378	CcSEcCtD
Solifenacin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00164	0.00378	CcSEcCtD
Solifenacin—Fatigue—Triamcinolone—ankylosing spondylitis	0.00164	0.00378	CcSEcCtD
Solifenacin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00163	0.00377	CcSEcCtD
Solifenacin—Angiopathy—Methotrexate—ankylosing spondylitis	0.0016	0.00369	CcSEcCtD
Solifenacin—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00159	0.00368	CcSEcCtD
Solifenacin—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00159	0.00367	CcSEcCtD
Solifenacin—Hypertension—Prednisone—ankylosing spondylitis	0.00159	0.00366	CcSEcCtD
Solifenacin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00156	0.00361	CcSEcCtD
Solifenacin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00156	0.0036	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00155	0.00358	CcSEcCtD
Solifenacin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00155	0.00357	CcSEcCtD
Solifenacin—Mental disorder—Methotrexate—ankylosing spondylitis	0.00155	0.00357	CcSEcCtD
Solifenacin—Malnutrition—Methotrexate—ankylosing spondylitis	0.00154	0.00354	CcSEcCtD
Solifenacin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00152	0.00351	CcSEcCtD
Solifenacin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00152	0.0035	CcSEcCtD
Solifenacin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00152	0.0035	CcSEcCtD
Solifenacin—Urticaria—Triamcinolone—ankylosing spondylitis	0.00151	0.00348	CcSEcCtD
Solifenacin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0015	0.00347	CcSEcCtD
Solifenacin—Dysgeusia—Methotrexate—ankylosing spondylitis	0.0015	0.00347	CcSEcCtD
Solifenacin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.0015	0.00346	CcSEcCtD
Solifenacin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.0015	0.00345	CcSEcCtD
Solifenacin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.0015	0.00345	CcSEcCtD
Solifenacin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.0015	0.00345	CcSEcCtD
Solifenacin—Infection—Prednisone—ankylosing spondylitis	0.00149	0.00344	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00149	0.00343	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00149	0.00343	CcSEcCtD
Solifenacin—Fatigue—Betamethasone—ankylosing spondylitis	0.00149	0.00343	CcSEcCtD
Solifenacin—Fatigue—Dexamethasone—ankylosing spondylitis	0.00149	0.00343	CcSEcCtD
Solifenacin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00147	0.00339	CcSEcCtD
Solifenacin—Tachycardia—Prednisone—ankylosing spondylitis	0.00146	0.00338	CcSEcCtD
Solifenacin—Skin disorder—Prednisone—ankylosing spondylitis	0.00146	0.00336	CcSEcCtD
Solifenacin—Vision blurred—Methotrexate—ankylosing spondylitis	0.00145	0.00334	CcSEcCtD
Solifenacin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00142	0.00327	CcSEcCtD
Solifenacin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00142	0.00327	CcSEcCtD
Solifenacin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00141	0.00325	CcSEcCtD
Solifenacin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00141	0.00325	CcSEcCtD
Solifenacin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.0014	0.00323	CcSEcCtD
Solifenacin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.0014	0.00322	CcSEcCtD
Solifenacin—Urticaria—Dexamethasone—ankylosing spondylitis	0.00137	0.00316	CcSEcCtD
Solifenacin—Urticaria—Betamethasone—ankylosing spondylitis	0.00137	0.00316	CcSEcCtD
Solifenacin—Dizziness—Prednisolone—ankylosing spondylitis	0.00137	0.00315	CcSEcCtD
Solifenacin—Asthenia—Triamcinolone—ankylosing spondylitis	0.00136	0.00314	CcSEcCtD
Solifenacin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00136	0.00314	CcSEcCtD
Solifenacin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00136	0.00314	CcSEcCtD
Solifenacin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00136	0.00313	CcSEcCtD
Solifenacin—Pruritus—Triamcinolone—ankylosing spondylitis	0.00134	0.0031	CcSEcCtD
Solifenacin—Cough—Methotrexate—ankylosing spondylitis	0.00134	0.00309	CcSEcCtD
Solifenacin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00134	0.00309	CcSEcCtD
Solifenacin—Dyspepsia—Prednisone—ankylosing spondylitis	0.00132	0.00305	CcSEcCtD
Solifenacin—Decreased appetite—Prednisone—ankylosing spondylitis	0.0013	0.00301	CcSEcCtD
Solifenacin—Rash—Prednisolone—ankylosing spondylitis	0.0013	0.003	CcSEcCtD
Solifenacin—Dermatitis—Prednisolone—ankylosing spondylitis	0.0013	0.003	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.0013	0.003	CcSEcCtD
Solifenacin—Fatigue—Prednisone—ankylosing spondylitis	0.00129	0.00298	CcSEcCtD
Solifenacin—Headache—Prednisolone—ankylosing spondylitis	0.00129	0.00298	CcSEcCtD
Solifenacin—Constipation—Prednisone—ankylosing spondylitis	0.00128	0.00296	CcSEcCtD
Solifenacin—Confusional state—Methotrexate—ankylosing spondylitis	0.00126	0.00292	CcSEcCtD
Solifenacin—Dizziness—Triamcinolone—ankylosing spondylitis	0.00126	0.0029	CcSEcCtD
Solifenacin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00125	0.00289	CcSEcCtD
Solifenacin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00125	0.00289	CcSEcCtD
Solifenacin—Infection—Methotrexate—ankylosing spondylitis	0.00125	0.00287	CcSEcCtD
Solifenacin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00124	0.00285	CcSEcCtD
Solifenacin—Asthenia—Dexamethasone—ankylosing spondylitis	0.00124	0.00285	CcSEcCtD
Solifenacin—Asthenia—Betamethasone—ankylosing spondylitis	0.00124	0.00285	CcSEcCtD
Solifenacin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00123	0.00284	CcSEcCtD
Solifenacin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00123	0.00283	CcSEcCtD
Solifenacin—Nausea—Prednisolone—ankylosing spondylitis	0.00123	0.00283	CcSEcCtD
Solifenacin—Pruritus—Dexamethasone—ankylosing spondylitis	0.00122	0.00281	CcSEcCtD
Solifenacin—Pruritus—Betamethasone—ankylosing spondylitis	0.00122	0.00281	CcSEcCtD
Solifenacin—Skin disorder—Methotrexate—ankylosing spondylitis	0.00122	0.00281	CcSEcCtD
Solifenacin—Vomiting—Triamcinolone—ankylosing spondylitis	0.00121	0.00278	CcSEcCtD
Solifenacin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.0012	0.00278	CcSEcCtD
Solifenacin—Rash—Triamcinolone—ankylosing spondylitis	0.0012	0.00276	CcSEcCtD
Solifenacin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.0012	0.00276	CcSEcCtD
Solifenacin—Rash—Methylprednisolone—ankylosing spondylitis	0.00119	0.00275	CcSEcCtD
Solifenacin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00119	0.00275	CcSEcCtD
Solifenacin—Urticaria—Prednisone—ankylosing spondylitis	0.00119	0.00275	CcSEcCtD
Solifenacin—Headache—Triamcinolone—ankylosing spondylitis	0.00119	0.00274	CcSEcCtD
Solifenacin—Headache—Methylprednisolone—ankylosing spondylitis	0.00119	0.00274	CcSEcCtD
Solifenacin—Abdominal pain—Prednisone—ankylosing spondylitis	0.00119	0.00274	CcSEcCtD
Solifenacin—Dizziness—Dexamethasone—ankylosing spondylitis	0.00114	0.00263	CcSEcCtD
Solifenacin—Dizziness—Betamethasone—ankylosing spondylitis	0.00114	0.00263	CcSEcCtD
Solifenacin—Nausea—Triamcinolone—ankylosing spondylitis	0.00113	0.0026	CcSEcCtD
Solifenacin—Nausea—Methylprednisolone—ankylosing spondylitis	0.00113	0.0026	CcSEcCtD
Solifenacin—Somnolence—Methotrexate—ankylosing spondylitis	0.00111	0.00257	CcSEcCtD
Solifenacin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00111	0.00255	CcSEcCtD
Solifenacin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.0011	0.00255	CcSEcCtD
Solifenacin—Vomiting—Betamethasone—ankylosing spondylitis	0.0011	0.00253	CcSEcCtD
Solifenacin—Vomiting—Dexamethasone—ankylosing spondylitis	0.0011	0.00253	CcSEcCtD
Solifenacin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00109	0.00251	CcSEcCtD
Solifenacin—Rash—Betamethasone—ankylosing spondylitis	0.00109	0.00251	CcSEcCtD
Solifenacin—Rash—Dexamethasone—ankylosing spondylitis	0.00109	0.00251	CcSEcCtD
Solifenacin—Dermatitis—Betamethasone—ankylosing spondylitis	0.00109	0.0025	CcSEcCtD
Solifenacin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00109	0.0025	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00108	0.0025	CcSEcCtD
Solifenacin—Fatigue—Methotrexate—ankylosing spondylitis	0.00108	0.00249	CcSEcCtD
Solifenacin—Headache—Dexamethasone—ankylosing spondylitis	0.00108	0.00249	CcSEcCtD
Solifenacin—Headache—Betamethasone—ankylosing spondylitis	0.00108	0.00249	CcSEcCtD
Solifenacin—Asthenia—Prednisone—ankylosing spondylitis	0.00108	0.00248	CcSEcCtD
Solifenacin—Pruritus—Prednisone—ankylosing spondylitis	0.00106	0.00245	CcSEcCtD
Solifenacin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00103	0.00238	CcSEcCtD
Solifenacin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00103	0.00236	CcSEcCtD
Solifenacin—Nausea—Dexamethasone—ankylosing spondylitis	0.00102	0.00236	CcSEcCtD
Solifenacin—Nausea—Betamethasone—ankylosing spondylitis	0.00102	0.00236	CcSEcCtD
Solifenacin—Urticaria—Methotrexate—ankylosing spondylitis	0.000996	0.0023	CcSEcCtD
Solifenacin—Dizziness—Prednisone—ankylosing spondylitis	0.000992	0.00229	CcSEcCtD
Solifenacin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000991	0.00229	CcSEcCtD
Solifenacin—Vomiting—Prednisone—ankylosing spondylitis	0.000954	0.0022	CcSEcCtD
Solifenacin—Rash—Prednisone—ankylosing spondylitis	0.000946	0.00218	CcSEcCtD
Solifenacin—Dermatitis—Prednisone—ankylosing spondylitis	0.000945	0.00218	CcSEcCtD
Solifenacin—Headache—Prednisone—ankylosing spondylitis	0.00094	0.00217	CcSEcCtD
Solifenacin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000924	0.00213	CcSEcCtD
Solifenacin—Asthenia—Methotrexate—ankylosing spondylitis	0.0009	0.00207	CcSEcCtD
Solifenacin—Nausea—Prednisone—ankylosing spondylitis	0.000891	0.00206	CcSEcCtD
Solifenacin—Pruritus—Methotrexate—ankylosing spondylitis	0.000887	0.00205	CcSEcCtD
Solifenacin—Dizziness—Methotrexate—ankylosing spondylitis	0.000829	0.00191	CcSEcCtD
Solifenacin—Vomiting—Methotrexate—ankylosing spondylitis	0.000797	0.00184	CcSEcCtD
Solifenacin—Rash—Methotrexate—ankylosing spondylitis	0.000791	0.00182	CcSEcCtD
Solifenacin—Dermatitis—Methotrexate—ankylosing spondylitis	0.00079	0.00182	CcSEcCtD
Solifenacin—Headache—Methotrexate—ankylosing spondylitis	0.000785	0.00181	CcSEcCtD
Solifenacin—Nausea—Methotrexate—ankylosing spondylitis	0.000745	0.00172	CcSEcCtD
